The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin).

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas

1978 • 1,663 citations

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]

1990 • 1,224 citations

Retinoids in cancer therapy.

1992 • 505 citations

Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins.

1992 • 441 citations

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1990 • 399 citations

Chemotherapy for malignant gliomas

1988 • 343 citations

Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells.

1991 • 279 citations

Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus.

1991 • 253 citations

Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines.

1991 • 209 citations

Effects of retinoic acid on the immune system: Stimulation of T killer cell induction

1978 • 192 citations

Intravenous carboplatin for recurrent malignant glioma: a phase II study.

1991 • 173 citations

Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.

1992 • 151 citations

Single-Agent Chemotherapy of Brain Tumors

1976 • 110 citations

Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A.

1988 • 92 citations

Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study.

1991 • 89 citations

Mechanism of action of retinoids

1986 • 86 citations

Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

1989 • 83 citations

Retinoic Acid Stimulation of the Induction of Mouse Killer T-Cells in Allogeneic and Syngeneic Systems<xref ref-type="fn" rid="FN1">2</xref>

1979 • 69 citations

Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells.

1989 • 64 citations

Clinical pharmacology of all-trans retinoic acid.

1994 • 62 citations

Modulation of all-trans retinoic acid pharmacokinetics by liarozole

1994 • 61 citations

Inhibition of growth and development of the transplantable C-6 glioma cells inoculated in rats by retinoids and carotenoids

1989 • 56 citations

Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid.

1989 • 49 citations

Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: Retinoic acid may induce IGF-2

1993 • 38 citations

Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.

1995 • 31 citations

Effects of retinoic acid on expression of the transformed phenotype in C6 glioma cells

1987 • 25 citations

Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia.

1994 • 24 citations

Advantage of Post-Radiotherapy Chemotherapy with CCNU, Procarbazine, and Vincristine (mPCV) Over Chemotherapy with VM-26 and CCNU for Malignant Gliomas

1992 • 23 citations

Chemotherapy for malignant brain tumors

1990 • 16 citations

Trans retinoic acid inhibitsin vivotumour growth of C6 glioma in rats: Effect negatively influenced by nerve growth factor

1994 • 16 citations

Cell Volume and Permeability of Oxygen- and Glucose-Deprived Retina in Vitro

1976 • 8 citations

Chemotherapy for malignant brain tumors.

1990 • 4 citations